The National Agency for the Control of AIDS (NACA) confirmed the news, saying the federal government is preparing to roll out ...

A brand new drug might be more effective at preventing HIV than current methods. Many people take daily oral antiretroviral medication—known as PrEP (pre-exposure prophylaxis)—to protect themselves ...

Nigeria is set to receive its first consignments of the landmark Lenacapavir, a new HIV prevention medicine, in March 2026, ...

A new HIV antiretroviral shows promise as a long-acting, oral prophylactic agent, according to a new study by Izzat Raheem, Tracy Diamond and colleagues from Merck & Co., Inc., Rahway, NJ, USA, ...

In their research article published in Eurosurveillance, von Schreeb et al. challenge existing assumptions regarding the relationship between the use of HIV pre-exposure prophylaxis (PrEP) and the ...

The federal government says consignments of Lenacapavir, a new drug for HIV prevention, are expected to arrive in Nigeria in March ...

Subdermal delivery of antiretrovirals shows promise in early trials Researchers at the University of California, San Francisco, have found that pre-exposure prophylaxis can be effective in preventing ...

A Gilead Sciences drug that protects against HIV infection has won a highly anticipated FDA approval, becoming the first medication for HIV prevention available as a twice-yearly injection. The ...

Postexposure HIV prophylaxis has been recommended for men who have sex with men, but the window to start treatment is short (72 hours) and evidence for its efficacy is limited. The recent Pre-exposure ...

Zimbabwe's health authorities on Thursday began administering the long-acting HIV prevention drug lenacapavir, making the ...

HIV Virus Creative artwork featuring colorized 3D prints of HIV virus particles. The virus surface (red) is covered with proteins (dark blue) that enable the virus to enter and infect human cells, and ...